Definitely not. I thought RH was pretty good and I think I had said last year that he was preaching a good message but needed a better audience. He did seem to go MIA this year but I assumed he was busy in the lab (but I guess we already have a CSO) and others more cynically said PYC won't be back till the next CR. Maybe there had been difference of opinions or other issues but whatever the truth we have an outcome. I had wondered whether he or PW were the right people to take us all the way but that too is a mute point now. In my experience with Aussie bio's I have found we are hugely successful with the science and R&D teams (peers) of international pharma but not so good at closing with the business types. If we end up appointing someone with those skills then you know we are close and the Board is moving in that direction.
PYC Price at posting:
1.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)